Introduction
Leading specialty chemicals manufacturer reported Q3 FY26 revenue of ₹581.7 crore, EBITDA of ₹68.9 crore, and net profit of ₹32.8 crore, showing steady year-on-year growth.
Also Read: CG Power rises 9% after securing massive ₹900 Cr transformer order for US data center project
Share price movement of Rossari Biotech
On January 20, 2026, Rossari Biotech Ltd opened at ₹521.30, down 0.14% from its previous close of ₹522.05. The stock reached a high of ₹566.05 (8.42%) and a low of ₹519.40 (-0.13%). By 10:54 AM, it traded at ₹534.85, a 2.45% increase, with a market cap of ₹2,962.07 crore.
Rossari Biotech Q3 Profit Rises
Rossari Biotech Limited reported Q3 FY26 consolidated revenue of ₹581.7 crore, rising 13% year-on-year from ₹512.7 crore, driven by improved demand across its specialty chemicals portfolio.
EBITDA for the quarter increased 6% year-on-year to ₹68.9 crore from ₹64.8 crore, while EBITDA margin declined to 11.8% compared with 12.6% in Q3 FY25.
Net profit after tax rose 3% year-on-year to ₹32.8 crore from ₹31.7 crore. Diluted earnings per share for Q3 FY26 stood at ₹5.9.
Stock performance of Rossari Biotech for Period of 1 week, 6 months, and 1 year
Rossari Biotech Ltd delivered a -4.24% return over the past week and declined 27.2% in the past 6 months. The stock fell 36.4% over the past 1 year.
Also Read: BHEL Q3 FY26: Profit jumps 190% YoY to ₹390 crore as revenue rises 16%
Shareholding pattern of Rossari Biotech
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 |
| Promoter | 68.20% | 68.20% | 68.20% |
| FII | 2.30% | 2.70% | 3.50% |
| DII | 18.30% | 18.20% | 17.80% |
| Public | 11.30% | 11.00% | 10.50% |
About Rossari Biotech
Rossari Biotech Limited (NSE: ROSSARI) is a Mumbai-based specialty chemicals manufacturer offering solutions in HPPC, textile, and animal health, with manufacturing units in Silvassa and Dahej.
Stay Ahead with the Latest Stock Market Updates – Click Here
Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.
FAQs
Q: Why is Rossari Biotech Ltd share price rising today?
A: Rossari Biotech Ltd share price is rising today after reporting Q3 FY26 revenue of ₹581.7 Cr, PAT of ₹32.8 Cr.
Q: What is Rossari Biotech Ltd’s main business focus?
A: Rossari Biotech focuses on specialty chemicals for HPPC, textile speciality, and animal health with manufacturing in Silvassa and Dahej.
Q: What is the 52-week high and low of Rossari Biotech Ltd stock?
A: Rossari Biotech stock’s 52-week high is ₹831.70 and the 52-week low is ₹519.40.


